Patients were classified with GPA or MPA according to the EMEA algorithm described previously [20] and, in addition, patients had to have either an MPO- or PR3-ANCA, or a diagnostic tissue biopsy with cANCA or pANCA. The gene discussed is MPO; the disease is granulomatosis with polyangiitis.